1. Home
  2. EDIT vs IEAG Comparison

EDIT vs IEAG Comparison

Compare EDIT & IEAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Editas Medicine Inc.

EDIT

Editas Medicine Inc.

N/A

Current Price

$1.63

Market Cap

422.3M

Sector

Health Care

ML Signal

N/A

Logo Infinite Eagle Acquisition Corp. Class A Ordinary Shares

IEAG

Infinite Eagle Acquisition Corp. Class A Ordinary Shares

N/A

Current Price

$10.13

Market Cap

443.0M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
EDIT
IEAG
Founded
2013
2025
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
422.3M
443.0M
IPO Year
2016
2025

Fundamental Metrics

Financial Performance
Metric
EDIT
IEAG
Price
$1.63
$10.13
Analyst Decision
Buy
Analyst Count
13
0
Target Price
★ $6.10
N/A
AVG Volume (30 Days)
★ 2.2M
121.4K
Earning Date
11-09-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
★ 37.50
N/A
EPS
N/A
★ N/A
Revenue
★ $31,937,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 132.64
N/A
52 Week Low
$1.66
$9.97
52 Week High
$3.94
$10.30

Technical Indicators

Market Signals
Indicator
EDIT
IEAG
Relative Strength Index (RSI) 29.08 55.77
Support Level N/A $9.98
Resistance Level $3.00 $10.18
Average True Range (ATR) 0.21 0.03
MACD -0.09 0.01
Stochastic Oscillator 1.10 100.00

Price Performance

Historical Comparison
EDIT
IEAG

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.

About IEAG Infinite Eagle Acquisition Corp. Class A Ordinary Shares

Infinite Eagle Acquisition Corp is a blank check company.

Share on Social Networks: